PedvaxHIB is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Haemophilus Influenzae Type B Capsular Polysaccharide Meningococcal Outer Membrane Protein Conjugate Antigen.
Product ID | 0006-4897_03e8f60a-7fe8-4dcc-933c-5ad199c03e53 |
NDC | 0006-4897 |
Product Type | Vaccine |
Proprietary Name | PedvaxHIB |
Generic Name | Haemophilus B Conjugate Vaccine (meningococcal Protein Conjugate) |
Dosage Form | Injection, Suspension |
Route of Administration | INTRAMUSCULAR |
Marketing Start Date | 1989-12-20 |
Marketing Category | BLA / BLA |
Application Number | BLA103237 |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN |
Active Ingredient Strength | 8 ug/.5mL |
Pharm Classes | Actively Acquired Immunity [PE],Haemophilus Vaccines [CS],Inactivated Haemophilus Influenzae B Vaccine [EPC],Vaccines, Inactivated [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1989-12-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103237 |
Product Type | VACCINE |
Billing Unit | ML |
Marketing Start Date | 2013-12-13 |
Marketing Category | BLA |
Application Number | BLA103237 |
Product Type | VACCINE |
Billing Unit | ML |
Marketing Start Date | 1989-12-20 |
Ingredient | Strength |
---|---|
HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN | 7.5 ug/.5mL |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() PEDVAXHIB 73796368 1610999 Live/Registered |
MERCK & CO., INC. 1989-04-28 |